Everything the podcasts said · one show
Excess Returns
Validea team on factor investing and market history.
636
Ideas · 7d
636
Ideas · 30d
636
Ideas · all time
63
Episodes
Latest attributed ideas · most recent first
24 JULThey Call It a Lottery Ticket. The Data Says Otherwise · 01:10
Biotech active alpha through specialized domain knowledge
“The guest argued that persistent active alpha exists in public development-stage biotech because valuing binary clinical outcomes requires domain-specific processing power that only specialized funds possess.”
Core thesis · 5/5Verify in source →
24 JULThey Call It a Lottery Ticket. The Data Says Otherwise · 02:15
The 'bag of options' biotech valuation framework
“The speaker presented a concept framework for valuing pre-commercial biotech companies by summing the net present values of individual clinical drug pipelines adjusted for phase transition probability base rates.”
Explored in depth · 4/5Verify in source →
24 JULThey Call It a Lottery Ticket. The Data Says Otherwise · 03:40
Granular AI integration accelerates drug discovery component parts
“The case was made that AI in biotech is driving investable efficiency gains by optimizing specific, individual steps of the drug discovery lifecycle rather than transforming drug discovery as a single monolithic process.”
In depth · 4/5Verify in source →
24 JULThey Call It a Lottery Ticket. The Data Says Otherwise · 08:15
China becomes key hub for early clinical trials
“The argument was presented that conducting early-stage human clinical trials in China provides biotech companies with critical speed and cost advantages due to faster patient enrollment and high-quality scientific infrastructure.”
In depth · 4/5Verify in source →
24 JULThey Call It a Lottery Ticket. The Data Says Otherwise · 07:15
24 JULThey Call It a Lottery Ticket. The Data Says Otherwise · 05:40
24 JULThey Call It a Lottery Ticket. The Data Says Otherwise · 01:35
24 JULThey Call It a Lottery Ticket. The Data Says Otherwise · 00:00
24 JULThe War Markets Can't Price · 08:22
24 JULThe War Markets Can't Price · 05:14
24 JULThe War Markets Can't Price · 01:21
24 JULThe War Markets Can't Price · 02:18
24 JULThe War Markets Can't Price · 13:45
24 JULThe War Markets Can't Price · 06:58
24 JULThe War Markets Can't Price · 10:35
24 JULThe War Markets Can't Price · 01:30
24 JULThe War Markets Can't Price · 03:10
24 JULThe War Markets Can't Price · 04:21
24 JULThe War Markets Can't Price · 03:15
24 JULThe War Markets Can't Price · 08:10
24 JULThe War Markets Can't Price · 06:12
24 JULThe War Markets Can't Price · 12:12
24 JULBig Decline. Options Support Gone · 01:20
24 JULBig Decline. Options Support Gone · 01:35
Caution advised as equity options gamma support fades
“The speakers argued that equity markets face downside risk and volatility spikes into the March options expiration as dealer gamma support at the 6,500 strike dissipates without a quick geopolitical or oil resolution.”
Core thesis · 5/5Verify in source →
24 JULBig Decline. Options Support Gone · 12:30
24 JULBig Decline. Options Support Gone · 04:30
24 JULBig Decline. Options Support Gone · 04:10
24 JULBig Decline. Options Support Gone · 02:15
24 JULBig Decline. Options Support Gone · 09:45
24 JULBig Decline. Options Support Gone · 01:25